East Melbourne

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Multiple myeloma

Running trials

• Active, not recruiting

  A Study to Evaluate Mezigdomide in Combination With Carfilzomib and Dexamethasone (MeziKD) Versus Carfilzomib and Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma (SUCCESSOR-2)

  NCT05552976· Phase 3· Bristol-Myers Squibb· Source